LYV - Live Nation +1.7% on higher price targets amid vaccine rollout

Live Nation Entertainment (LYV) is up 1.7% after a pair of price target hikes from analysts processing the company's 2021 prospects. Cowen reiterated its Outperform rating, and raised its target to $85 from $62, implying 18% upside. The firm expects stronger competitive positioning by the company for fans, artists and brands vs. pre-pandemic era. Atlantic Equities also raised its target to $85, from $70. It's pointing to the vaccine developments (and their enablement of a potential eventual return to normal concertgoing life) as well as stronger-than-expected 2022 concert activity. While the Street is still Bullish on the stock, Seeking Alpha authors are Bearish, and it has a Quant Rating of Bearish.

For further details see:

Live Nation +1.7% on higher price targets amid vaccine rollout